Quality Certification Integrated Analytical Solutions holds ISO/IEC 17025:2017 accreditation and multiple licenses (NJCRC, DEA Schedule 1, NJ Controlled Dangerous Substance), signaling high credibility and regulatory alignment for cannabis testing. This presents a sales opportunity to expand collaborations with licensed operators seeking compliant labs and to target new market entrants requiring validated analytical partners.

Cannabis Focus Specialized in cannabis quality testing with services spanning cannabinoids, terpenes, pesticides, heavy metals, solvents, mycotoxins, moisture, water activity, and pathogens. Target growers, processors, and distributors seeking end-to-end QC solutions and faster turnaround to support product launches and regulatory submissions.

Strategic Acquisition Past acquisition by Genesis Biotechnology Group indicates potential for integration into a broader biotech ecosystem and cross-sell opportunities. Propose joint offerings or referral partnerships with affiliated entities to reach a wider customer base and leverage shared resources.

Limited Revenue Scale Current revenue range ($1M-$10M) and small employee count (2-10) suggest lean operations with potential for scalable lab capacity. Sales plays could emphasize flexible capacity, rapid expansion of testing menus, and capacity planning for seasonal testing surges in the cannabis market.

Digital & Security Posture Tech stack includes HubSpot, Cloudflare, and security provisions, indicating a modern digital presence and data protection posture. Leverage as a selling point for customers prioritizing secure data handling, API integrations, and streamlined submission portals for sample intake and result reporting.